Article info

Original research
Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial

Authors

  1. Correspondence to Dr Aung Naing; anaing{at}mdanderson.org; Dr Kanwal P Raghav; KPRaghav{at}mdanderson.org
View Full Text

Citation

Raghav KP, Stephen B, Karp DD, et al
Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial

Publication history

  • Accepted April 4, 2022
  • First published May 20, 2022.
Online issue publication 
May 20, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.